Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial

Indian Journal of Pharmacology

Volumn 43, Issue 6, 2011, Pages 628-631

  Choudhury, S ^a   Chatterjee, S ^a   Sarkar, D K ^a   Dutta, R N ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acne vulgaris; clindamycin; nadifloxacin; randomized controlled trial

Indexed keywords

BENZOYL PEROXIDE; CLINDAMYCIN; NADIFLOXACIN;

ACNE VULGARIS; ADULT; APPLICATION SITE DRYNESS; BURNING SENSATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

EID: 81855228766     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.89815     Document Type: Conference Paper

References (15)

1. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of Acne, A report from a global alliance to improve outcomes of acne. J Am Acad Dermatol 2003;49(suppl):S1-37.
2. Zaenglein AL, Graber EM, Thiboutot DM, Strauss JS. Acne vulgaris and acneiform eruption in Fitzpatrick's Dermatology in general medicine. 7 th ed. In: Wolff K et al, editors. New York: McGraw Hill; 2008. p. 687-703.
3. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003;49:S1-37.
4. Ross JI, Snelling AM, Caenegie E, Coates P, Cunliffe WJ, Bettoli V, et al. Antibiotic resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78. (Pubitemid 36461325)
5. Weiss J. Current options of topical treatment of acne vulgaris. Pediatr Dermatol 1997; 14:480-8. (Pubitemid 28012033)
6. Degitz K, Ochsendorf F. Pharmacotherapy of acne. Pharmacother 2008;9:955-71. (Pubitemid 351593743)
7. Kubba A, Bajaj AK, Thappa DM, Sharma R, Vedamurthy M, Dhar S. Acne in India: Guidelines for management-IAA consensus document: Topical antibacterials. Indian J Dermatol Venereol Leprol 2009;75(Suppl 1):1-62.
8. Schfer H, Gollner A, Kusche W, Schwantes U. Effectiveness and tolerance of topical nadifloxacin in the therapy of acne vulgaris (grade I-II): Results of non-interventional trial in 555 patients. J Appl Res 2009;9:44-51.
9. Nenoff P, Haustein UF, Hittel N. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic gram positive bacteria isolated from bacterial skin infections. Chemotherapy 2004;50:196-201. (Pubitemid 39482551)
10. Alba V, Urban E, Angeles Dominguez M, Nagy E, Nord CE, Palacin C. In vitro activity of nadifloxacin against several gram positive bacteria and analysis of possible evolution of resistance after two years of use in Germany. Int J Antimicrob Agents 2009;33:272-5.
11. Hayashi N, Akamatsu H, Kawashima M. Establishment of grading criteria for acne severity. J Dermatol 2008;35:255-60. (Pubitemid 351678090)
12. Gupta M, Johnson AM, Gupta AK. The development of an acne quality of life scale: Reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 1998;78:451-6. (Pubitemid 28505962)
13. Kuwahara K, Kitazawa T, Kitagaki H, Tsukamoto T, Kikuchi M. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 2005;38:47-55. (Pubitemid 40410630)
14. Cldmtkenkyukai. Phase III Clinical Study of Clindamycin Phosphate Topical Gel (CLDM-T) in the treatment of acne vulgaris-randomized comparative study with nadifloxacin cream as a control drug. J Clin Therap Med 1999;15:603-28.
15. Jung YJ, Kwon HH, Yeom KB, Yoon MY, Suh DH. Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients. Int J Dermatol 2011;50:350-7.